miodrag ignjatovic / iStockphoto.com
12 February 2018Asia-Pacific
Allergan to buy Australian tissue repair company for $95m
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
2 February 2018 Seattle Genetics has announced that it will acquire biotech company Cascadian Therapeutics for approximately $614 million.
Americas
6 March 2018 Mylan has revealed plans to develop and commercialise a proposed biosimilar to Botox.
Americas
18 September 2018 Allergan has revealed plans to buy Bonti, a biotechnology company focused on medical aesthetics, for $195 million.
Editor's picks
Editor's picks
Americas
6 March 2018 Mylan has revealed plans to develop and commercialise a proposed biosimilar to Botox.
Americas
18 September 2018 Allergan has revealed plans to buy Bonti, a biotechnology company focused on medical aesthetics, for $195 million.
Americas
2 February 2018 Seattle Genetics has announced that it will acquire biotech company Cascadian Therapeutics for approximately $614 million.
Americas
6 March 2018 Mylan has revealed plans to develop and commercialise a proposed biosimilar to Botox.
Americas
18 September 2018 Allergan has revealed plans to buy Bonti, a biotechnology company focused on medical aesthetics, for $195 million.
Americas
2 February 2018 Seattle Genetics has announced that it will acquire biotech company Cascadian Therapeutics for approximately $614 million.